P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation

Oriol Casanovas1, Montserrat Jaumot, Ana-Belén Paules

  • 1Departament de Biologia Cel lular i Anatomia Patològica, Facultat de Medicina, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Casanova 143, 08036, Spain.

Oncogene
|August 25, 2004
PubMed

Insights

Cyclin D3 degradation is essential for T-cell maturation and is regulated by p38SAPK kinases phosphorylating Thr-283. Dysregulation of this pathway may contribute to lymphoid cancers.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Cyclin D3 is crucial for precursor T-cell maturation.
  • Its tightly regulated levels are implicated in lymphoid malignancies.

Purpose of the Study:

  • To investigate the mechanisms regulating cyclin D3 levels.
  • To identify kinases involved in cyclin D3 regulation.

Main Methods:

  • Proteasome inhibition assays.
  • Analysis of ubiquitylation and degradation.
  • Kinase activity assays using p38SAPK family members.

Main Results:

  • Cyclin D3 degradation occurs via the proteasome, dependent on Thr-283 phosphorylation.
  • Stress conditions induce Thr-283-dependent cyclin D3 degradation.
  • p38SAPK kinases, including p38alphaSAPK2, phosphorylate cyclin D3 at Thr-283, leading to decreased cyclin D3 levels.

Conclusions:

  • p38SAPK-mediated phosphorylation of cyclin D3 at Thr-283 regulates its degradation.
  • This mechanism is vital for T-cell maturation.
  • Aberrations in this pathway may play a role in oncogenesis.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...